Legius syndrome

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tom.Reding (talk | contribs) at 00:27, 30 June 2016 (→‎References: Rem stub tag(s) (class = non-stub & non-list) using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Legius syndrome

Legius syndrome (LS) is an autosomal dominant condition characterized by cafe au lait spots.[1] It was first described in 2007 and is often mistaken for Neurofibromatosis type I (NF-1). It is caused by mutations in the SPRED1 gene.[2][3][4] It is also known as Neurofibromatosis Type 1-like syndrome (NFLS). The syndrome is named after Eric Legius, Professor at the KU Leuven. It is a RASopathy.

Symptoms

Nearly all patients show multiple Café au lait spots. Other symptoms may include:

Features common in neurofibromatosis - Lisch nodules, bone abnormalities, neurofibromas, optic pathway gliomas and malignant peripheral nerve sheath tumors - are absent in this condition.

Diagnosis

Genetic testing is necessary to identify the syndrome. The test checks for loss of function mutations in the SPRED1 gene.

Confusion with Neurofibromatosis Type I

The symptoms of Legius syndrome and NF-1 are very similar. This is the reason why the two are easily confused. A genetic test is often the only way to make sure a person has LS and not NF-1. The similarity of symptoms stem from the fact that the different genes affected in the two syndromes code for proteins that carry out a similar task in the same reaction pathway.

An important difference is the absence of tumor growths (Lisch nodules and Neurofibromas which are common in NF-1) in LS.[5]

Because of this difference, Legius syndrome is often seen as the less severe of the two syndromes.

Disease Database

SPRED1 gene variant database

See also

References